International Session (Symposium)1 (JSGE, JGES, JSGS, JSGCS)

Diagnosis and carcinogenesis of Barrett’s esophagus in the world

• Chairperson:
  Katsunori IijimaDepartment of Gastroenterology, Akita University Graduate School of Medicine
• Chairperson:
  Takuji GotodaDivision of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine

IS-S1-1_G
Diagnostic Conundrums of Gastroesophageal Junctional Adenocarcinoma and Barrett Esophagus in Asia

IS-S1-2_G
Ongoing changes in endoscopic appearance of the esophageal-gastric junction and stomch in young Japanese

IS-S1-3_G
Analysis of Barrett's esophagus and risk factors

IS-S1-4_G
Endoscopic evidence of bile reflux may predict the development of Barrett's esophagus

IS-S1-5_G
Low risk of esophageal adenocarcinoma among patients with ultrashort-segment Barrett's esophagus in Japan

IS-S1-6_G
The location of Barrett's adenocarcinoma is related to the esophageal reflux factor and the baseline value of MII Young Award

IS-S1-7_G
Evolution of DNA methylome from Barrett's esophagus to adenocarcinoma and their magnifying narrow-band imaging features

IS-S1-8_G
Diagnosis and treatment of barrett's esophagus in the west

International Session (Symposium)2 (JSH, JSGE)

From basic to clinical research: The strategy for new treatments for liver fibrosis and cirrhosis

• Chairperson:
  Hitoshi YoshijiDepartment of Gastroenterology, Nara Medical University
• Chairperson:
  Shuji TeraiDivision of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University
• Discussant:
  Hayato HikitaDepartment of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine

IS-S2-1_H
Microbiome correlated with fibrosis markers common to HBV and HCV patients

IS-S2-2_H
ARB potentiate the Protective Effect of BCAA on Skeletal Muscle Atrophy in Cirrhotic Rats

IS-S2-3_H
Pro-fibrolytic Myeloid TLR4 Signaling for Resolution of Murine Liver Fibrosis: Roles of Gut Microbiome-Bile Acid Axis

IS-S2-4_H
Impact of LSECs on liver fibrogenesis in congestive liver Young Award

IS-S2-5_H
C1q mediated hepatic stellate cell activation associated with CTGF elevation and is a prognostic factor for survival in rat and human chronic liver diseases.

IS-S2-6_H
Experimental fibrosis alters matrix-bound vesicles cargo that do not revert after histologic recovery

IS-S2-7_G
Engineering of human liver progenitor-like cells for a new exosomal thrapy of liver fibrosis

IS-S2-8_H
Skeletal myoblast cell-sheet transplantation for liver fibrosis in mice

IS-S2-9_H
Mesenchymal stem cell and exosome therapies for liver cirrhosis

IS-S2-10_G
Safety, tolerability, and anti-fibrotic efficacy of the CBP/β-catenin inhibitor PRI-724 in patients with hepatitis C and B virus induced liver cirrhosis

International Session (Symposium)3 (JSGS, JSGE)

Current evidence and technical challenges for laparoscopic surgery for far advanced gastric cancer

• Chairperson:
  Shuji TakiguchiDepartment of Gastroenterological Surgery, Nagoya City University
• Chairperson:
  Naoki HikiDepartment of Upper Gastrointestinal Surgery, Kitasato University School of Medicine

IS-S3-Keynote Lecture
Survival outcomes of laparoscopy-assisted distal gastrectomy for locally advanced gastric cancer (JLSSG0901)

IS-S3-1_S
A prospective study for safety margins during laparoscopic distal gastrectomy for advanced gastric cancer

IS-S3-2_S
Current evidence and technical challenges for laparoscopic surgery for advanced gastric cancer

IS-S3-3_S
Intraoperative Management Tips for Avoiding Cancer Dissemination in Laparoscopic/Robotic Gastrectomy for Far Advanced Gastric Cancer

IS-S3-4_S
Robotic surgery opens up new avenues for highly advanced gastric cancer

IS-S3-5_S
The usefulness of robotic surgery for advanced gastric cancer

IS-S3-6_S
Clinical advantage of robotic gastrectomy following preoperative chemotherapy for advanced gastric cancer

International Session (Symposium)4 (JGES, JSGE, JSGS, JSGCS)

Globally demanded novel technologies and future perspectives for therapeutic upper GI endoscopy

• Chairperson:
  Noriya UedoDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute
• Chairperson:
  Kazuki SumiyamaDepartment of Endoscopy, The Jikei University School of Medicine
• Discussant:
  Motohiko KatoDivision of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine

IS-S4-Keynote Lecture
Current and Future advances in AI and Robotics for GI Endoscopy

IS-S4-1_E
Novel Simulator for Endoscopic Hemostasis Provides Opportunity to Foster Confidence and Interest in Endoscopic Therapy for Diverse Learners

IS-S4-2_S
Outcomes of endoscopic removal of gastrointestinal stromal tumor of the stomach

IS-S4-3_E
Development of a compact stapler for flexible endoscope aimed at full-thickness closure in the field of gastrointestinal tract

IS-S4-4_E
Feasibility of O-ring and Over-The-Scope Clip closure after gastric endoscopic full-thickness resection: From animal experience to clinical introduction

IS-S4-5_E
Newly anchor deployment suturing device - current status and future perspectives-

IS-S4-6_G
Introduction of an endoscopic suturing system from animal study to the clinical setting in Japan

IS-S4-7_E
Our challenges in advanced therapeutic endoscopy Young Award

IS-S4-Special Remarks

International Session (Symposium)5 (JSGS, JSGE, JGES, JSH)

The role of surgical resection for distant metastasis of colorectal cancer

• Chairperson:
  Hiroaki NaganoDepartment of Gastroenterological Surgery, Yamaguchi University Graduate School of Medicine
• Chairperson:
  Hideki UenoDepartment of Surgery, National Defense Medical College

IS-S5-1_S
Examination of prognostic risk factors for colorectal cancer patients with liver metastasis and future strategies in our department

IS-S5-2_S
Surgical resection for multiple liver metastasis of colorectal cancer: Is there a limit in number and procedure?

IS-S5-3_G
Reverse Approach as Preferred Strategy for Synchronous Rectal Cancer withLiver Metastases Travel Award

IS-S5-4_S
Surgical aspects of conversion therapy for initially unresectatble colorectal liver metastases

IS-S5-5_S
Development of Scoring model of Conversion Surgery for technically unresectable liver metastases. Young Award

IS-S5-6_S
Addition of pre-and/or post-hepatectomy chemotherapy to liver resection was not associated with improved survival in patients with resectable colorectal liver metastases: IPTW analysis

IS-S5-7_S
Does surgical intervention contribute to survival for CRC with isolated PALN metastasis in the era of new anticancer drugs?

IS-S5-8_S
Recent strategy for colorectal peritoneal carcinomatosis especially focusing on the tumor location

IS-S5-9_S
Surgical resection for synchronous peritoneal metastasis from colorectal cancer: A prospective multi-institutional observational study